These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11592437)

  • 21. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
    Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine and endothelial function in human studies.
    Moat SJ; McDowell IF
    Semin Vasc Med; 2005 May; 5(2):172-82. PubMed ID: 16047269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated.
    Kaul S; Zadeh AA; Shah PK
    J Am Coll Cardiol; 2006 Sep; 48(5):914-23. PubMed ID: 16949480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
    Riba R; Nicolaou A; Troxler M; Homer-Vaniasinkam S; Naseem KM
    Atherosclerosis; 2004 Jul; 175(1):69-75. PubMed ID: 15186948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine, vitamin B12 and folic acid levels in psoriasis patients.
    Cakmak SK; Gül U; Kiliç C; Gönül M; Soylu S; Kiliç A
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):300-3. PubMed ID: 19207655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.
    Wilcken DE
    J Cardiovasc Risk; 1998 Aug; 5(4):217-21. PubMed ID: 9919468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperhomocysteinemia and atherothrombotic disease.
    de Jong SC; van den Berg M; Rauwerda JA; Stehouwer CD
    Semin Thromb Hemost; 1998; 24(4):381-5. PubMed ID: 9763355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
    Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
    Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Homocystein--an independent risk factor for cardiovascular and thrombotic diseases].
    Fowler B
    Ther Umsch; 2005 Sep; 62(9):641-6. PubMed ID: 16218503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Homocysteine as a nonlipid factor in the pathogenesis of atherosclerosis].
    Magott M
    Postepy Hig Med Dosw; 1998; 52(3):259-67. PubMed ID: 9789435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methionine loading does not enhance the predictive value of homocysteine serum testing for all-cause mortality or major adverse cardiac events.
    Dunkelgrun M; Hoeks SE; Schouten O; Feringa HH; Welten GM; Vidakovic R; van Gestel YR; van Domburg RT; Goei D; de Jonge R; Lindemans J; Poldermans D
    Intern Med J; 2009 Jan; 39(1):13-8. PubMed ID: 18336539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocysteine and arterial thrombosis: Challenge and opportunity.
    Di Minno MN; Tremoli E; Coppola A; Lupoli R; Di Minno G
    Thromb Haemost; 2010 May; 103(5):942-61. PubMed ID: 20352150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of homocysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss.
    Nadir Y; Hoffman R; Brenner B
    Ann Hematol; 2007 Jan; 86(1):35-40. PubMed ID: 17043779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperhomocysteinaemia and atherothrombosis.
    Cattaneo M
    Ann Med; 2000 Dec; 32 Suppl 1():46-52. PubMed ID: 11209982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folate, homocysteine, endothelial function and cardiovascular disease.
    Moat SJ; Lang D; McDowell IF; Clarke ZL; Madhavan AK; Lewis MJ; Goodfellow J
    J Nutr Biochem; 2004 Feb; 15(2):64-79. PubMed ID: 14972346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-vitamin levels and genetics of hyperhomocysteinemia are not associated with arterial stiffness.
    van Dijk SC; Enneman AW; van Meurs J; Swart KM; Ham AH; van Wijngaarden JP; Brouwer-Brolsma EM; van der Zwaluw NL; van Schoor NM; Dhonukshe-Rutten RA; de Groot LC; Lips P; Uitterlinden AG; Blom H; Geleijnse JM; Feskens E; de Jongh RT; Smulders YM; van den Meiracker AH; Mattace-Raso FU; van der Velde N
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):760-6. PubMed ID: 24656138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
    Unlü Y; Keleş S; Becit N; Koçoğullari CU; Koçak H; Bakan E
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):315-8. PubMed ID: 15963742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine, oxidative stress, and vascular disease.
    Welch GN; Upchurch GR; Loscalzo J
    Hosp Pract (1995); 1997 Jun; 32(6):81-2, 85, 88-92. PubMed ID: 9194803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.